Kindred John H, Ketelhut Nathaniel B, Rudroff Thorsten
Department of Health and Exercise Science, Integrative Neurophysiology Lab, Colorado State University, Fort Collins, CO, USA.
Clin Biomech (Bristol). 2015 Feb;30(2):159-65. doi: 10.1016/j.clinbiomech.2014.12.005. Epub 2014 Dec 17.
Difficulties in ambulation are one of the main problems reported by patients with multiple sclerosis. A previous study by our research group showed increased recruitment of muscle groups during walking, but the influence of skeletal muscle properties, such as muscle fiber activity, has not been fully elucidated. The purpose of this investigation was to use the novel method of calculating glucose uptake heterogeneity in the leg muscles of patients with multiple sclerosis and compare these results to healthy controls.
Eight patients with multiple sclerosis (4 men) and 8 healthy controls (4 men) performed 15 min of treadmill walking at a comfortable self-selected speed following muscle strength tests. Participants were injected with ≈ 8 mCi of [(18)F]-fluorodeoxyglucose during walking after which positron emission tomography/computed tomography imaging was performed.
No differences in muscle strength were detected between multiple sclerosis and control groups (P>0.27). Within the multiple sclerosis, group differences in muscle volume existed between the stronger and weaker legs in the vastus lateralis, semitendinosus, and semimembranosus (P<0.03). Glucose uptake heterogeneity between the groups was not different for any muscle group or individual muscle of the legs (P>0.16, P≥0.05).
Patients with multiple sclerosis and healthy controls showed similar muscle fiber activity during walking. Interpretations of these results, with respect to our previous study, suggest that walking difficulties in patients with multiple sclerosis may be more associated with altered central nervous system motor patterns rather than alterations in skeletal muscle properties.
行走困难是多发性硬化症患者报告的主要问题之一。我们研究小组之前的一项研究表明,行走过程中肌肉群的募集增加,但骨骼肌特性(如肌纤维活动)的影响尚未完全阐明。本研究的目的是使用新方法计算多发性硬化症患者腿部肌肉的葡萄糖摄取异质性,并将这些结果与健康对照组进行比较。
8名多发性硬化症患者(4名男性)和8名健康对照者(4名男性)在进行肌肉力量测试后,以舒适的自选速度在跑步机上行走15分钟。参与者在行走过程中注射了约8毫居里的[(18)F]-氟脱氧葡萄糖,之后进行正电子发射断层扫描/计算机断层扫描成像。
多发性硬化症组和对照组之间未检测到肌肉力量差异(P>0.27)。在多发性硬化症组中,股外侧肌、半腱肌和半膜肌中较强和较弱腿部之间存在肌肉体积的组间差异(P<0.03)。两组之间腿部任何肌肉群或单个肌肉的葡萄糖摄取异质性均无差异(P>0.16,P≥0.05)。
多发性硬化症患者和健康对照者在行走过程中表现出相似的肌纤维活动。结合我们之前的研究对这些结果进行解读,提示多发性硬化症患者的行走困难可能更多与中枢神经系统运动模式改变有关,而非骨骼肌特性改变。